DoW Rare Cancers Idea Development Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Publicada 17 jun 2026 · Quedan 41 días
En pocas palabras
Resumen aún no disponible en español; se muestra en inglés.
The US Defense Health Agency funds research ideas on rare cancers that show promise for high-impact findings and new research directions, with preliminary data required. The programme is open to any type of organisation based in the United States, with applications due by 18 November 2026.
Un resumen generado del texto del donante; la redacción original figura más abajo.
Resumen
Texto original del donante (inglés)
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.
Distinctive Features:
The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
Research should have high potential impact on rare cancers and the patient community.
Extracto de la página del donante. El texto completo, los anexos y los formularios están en la convocatoria original.
Quién puede presentar una solicitud
- ONG / sociedad civil
- Institución académica o de investigación
- Empresa privada
- Organismo gubernamental
- Empresa social o cooperativa
- Persona física
- Agencia de la ONU u organismo intergubernamental
- Otro tipo de solicitante
Elegibilidad y condiciones
Mostrar el texto de elegibilidad de la fuente · Texto original del donante (inglés)
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"